Clinical Trials Browser

OTHER × Lymphoma, Follicular × Bevacizumab × Clear all

NCT01954030 2016-02-19

Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure

Phase 1 Terminated

Glioma, Lymphoma, Follicular

NCT00193492 2015-01-05

A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma

Phase 2 Completed

60 enrolled 7 charts

Lymphoma, Lymphoma, Follicular